DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 133 filers reported holding DERMIRA INC in Q4 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,237,000 | +216.4% | 807,191 | +33.3% | 0.10% | +174.3% |
| Q3 2019 | $3,868,000 | -31.0% | 605,339 | +3.2% | 0.04% | -31.4% |
| Q2 2019 | $5,608,000 | -24.0% | 586,560 | +7.7% | 0.05% | -27.1% |
| Q1 2019 | $7,378,000 | +57.4% | 544,500 | -16.5% | 0.07% | +37.3% |
| Q4 2018 | $4,688,000 | – | 652,073 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
| NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
| GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
| APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
| NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
| Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
| Jeneq Management LP | 96,570 | $923,000 | 0.82% |
| Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
| PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
| Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |